- Product category
-
Human cells
- Organism
-
Homo sapiens, human
- Cell type
- goblet
- Morphology
- epithelial
- Tissue
- Large intestine; Colon
- Disease
-
Adenocarcinoma; Colorectal; Dukes' type B
- Applications
-
3D cell cultureGastroenterology
- Product format
- Frozen
- Storage conditions
-
Vapor phase of liquid nitrogen
Documentation
ATCC determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services. It is your responsibility to understand the hazards associated with the material per your organization’s policies and procedures as well as any other applicable regulations as enforced by your local or national agencies.
ATCC highly recommends that appropriate personal protective equipment is always used when handling vials. For cultures that require storage in liquid nitrogen, it is important to note that some vials may leak when submersed in liquid nitrogen and will slowly fill with liquid nitrogen. Upon thawing, the conversion of the liquid nitrogen back to its gas phase may result in the vial exploding or blowing off its cap with dangerous force creating flying debris. Unless necessary, ATCC recommends that these cultures be stored in the vapor phase of liquid nitrogen rather than submersed in liquid nitrogen.
Detailed product information
General
- Specific applications
- In addition to cancer research, this cell line can be used in the Gastrointestinal (GI) Barrier Model and functions as secreting goblet cells. It can be used to investigate mucus regulation in the gut and its role in drug permeation.
Characteristics
- Growth properties
- Mixed: adherent and suspension
- Age
- 58 years
- Ethnicity
- White
- Sex
- Female
- Karyotype
-
modal number = 45; range = 42 to 47.
The stemline karyotype was 45,t(X;5) (q12;q31) with tetraploid-like cells occurring at 2.2 percent. Occasional changes in karyotypes were also noted as a result of balanced translocations producing new marker chromosomes. In conjunction with this, decreases in chromosomes involving interchromosomal exchanges were seen. The karyotype was exactly the same as that originally described by the depositor. - Tumorigenic
-
Yes; Yes, in nude mice
- Antigen expression
-
Serologically defined colon cancer antigen 3; Homo sapiens, expressedHLA A2, B13, B50; Blood type O
- Genes expressed
- carcinoembryonic antigen (CEA); interleukin 10; interleukin 6; mucin
- Isoenzymes
-
ADA, 1ES-D, 1G6PD, BPEP-D, 1PGD, APGM1, 1PGM3, 2
- Technical information
-
ATCC Product Experience does not have technical information on patent deposits that are not produced or characterized by ATCC. Additional information can be found in the corresponding patent available from the patent holder or with the U.S. and/or international patent office.
Handling information
- Unpacking and storage instructions
-
- Check all containers for leakage or breakage.
- Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
- Complete medium
-
The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%..
Example media preparation:
- 500 mL EMEM (ATCC 30-2003)
- 56 mL FBS (ATCC 30-2020) – not heat-inactivated
- Temperature
-
37°C
- Handling procedure
-
To ensure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.
- Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 minutes).
- Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.
- Transfer the vial contents to a centrifuge tube containing 9.0 mL complete culture medium. and spin at approximately 150 to 400 x g for 8 to 12 minutes (280 x g for 10 minutes). Discard supernatant.
- Resuspend cell pellet with the recommended complete growth medium (see the lot information on Certificate of Analysis (COA) for the culture recommended dilution ratio) and dispense into a 25 cm2 or a 75 cm2 culture flask as recommended on the COA. The recommended seeding density for CL-187 is 3.0 x 104 to 7.0 x 104 viable cells/cm2. It is important to avoid excessive alkalinity of the medium during recovery of the cells. It is suggested that, prior to the addition of the vial contents, the culture vessel containing the complete growth medium be placed into the incubator for at least 15 minutes to allow the medium to reach its normal pH (7.0 to 7.6).
- Incubate the culture at 37°C in a suitable incubator. A 5% CO2 in air atmosphere is recommended if using the medium described on this product sheet.
- Subculturing procedure
-
Subculture Restrictions: Floaters and adherent cells are kept during subculture
Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.- Remove and discard culture medium.
- Briefly rinse the cell layer with D-PBS (ATCC 30-2200) to remove all traces of serum which contains trypsin inhibitor.
- Add 2.0 to 3.0 mL 0.25% Trypsin/o.53 mM EDTA (ATCC 30-2101) to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
- Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.
Note: Removal of dissociation agent is not necessary. But if there is problem with reattachment after passaging try gently centrifuging cells and resuspending in fresh medium. - Add appropriate aliquots of the cell suspension to new culture vessels.
- Incubate cultures at 37°C.
Subcultivation Ratio/ Subculture seeding density: A subcultivation ratio of 1:2 to 1:5 is recommended or subculture at a seeding density of 2.0 x 104 to 7.0 x 104 viable cells/cm2
Medium Renewal: Two to three times per week
Recommendation: Fluid change one day before freeze improves viability. - Reagents for cryopreservation
- Complete growth medium supplemented with 5% (v/v) DMSO (ATCC 4-X)
Quality control specifications
- Mycoplasma contamination
- Not detected
- STR profiling
- Amelogenin: X CSF1PO: 10,13 D13S317: 10 D16S539: 11,13 D5S818: 10,15 D7S820: 9.3,11 TH01: 6,7 TPOX: 8,9 vWA: 15,18 D3S1358: 15,17 D21S11: 29,31 D18S51: 11,13 Penta_E: 15,16 Penta_D: 10 D8S1179: 12,16 FGA: 21,22 D19S433: 14,15 D2S1338: 18,22
History
- Deposited as
- Homo sapiens
- Depositors
- Northwestern University
- Patent depository
-
This material was deposited with the ATCC Patent Depository to fulfill U.S. or international patent requirements. This material may not have been produced or characterized by ATCC. As an International Depository Authority (IDA) for patent deposits, ATCC is required to complete viability testing only at time of initial deposit of patent material. Patent deposits are made available on behalf of the Depositor when the pertinent U.S. or international patent is issued, but material may not be used to infringe the patent claims.
- Patent number
-
4,228,236
Legal disclaimers
- Intended use
- This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
- Warranty
-
The product is provided 'AS IS' and the viability of ATCC® products is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product information sheet, website, and Certificate of Analysis. For living cultures, ATCC lists the media formulation and reagents that have been found to be effective for the product. While other unspecified media and reagents may also produce satisfactory results, a change in the ATCC and/or depositor-recommended protocols may affect the recovery, growth, and/or function of the product. If an alternative medium formulation or reagent is used, the ATCC warranty for viability is no longer valid. Except as expressly set forth herein, no other warranties of any kind are provided, express or implied, including, but not limited to, any implied warranties of merchantability, fitness for a particular purpose, manufacture according to cGMP standards, typicality, safety, accuracy, and/or noninfringement.
- Disclaimers
-
This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from ATCC.
While ATCC uses reasonable efforts to include accurate and up-to-date information on this product sheet, ATCC makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. ATCC does not warrant that such information has been confirmed to be accurate or complete and the customer bears the sole responsibility of confirming the accuracy and completeness of any such information.
This product is sent on the condition that the customer is responsible for and assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, and use of the ATCC product including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. As a condition of receiving the material, the customer agrees that any activity undertaken with the ATCC product and any progeny or modifications will be conducted in compliance with all applicable laws, regulations, and guidelines. This product is provided 'AS IS' with no representations or warranties whatsoever except as expressly set forth herein and in no event shall ATCC, its parents, subsidiaries, directors, officers, agents, employees, assigns, successors, and affiliates be liable for indirect, special, incidental, or consequential damages of any kind in connection with or arising out of the customer's use of the product. While reasonable effort is made to ensure authenticity and reliability of materials on deposit, ATCC is not liable for damages arising from the misidentification or misrepresentation of such materials.
Please see the material transfer agreement (MTA) for further details regarding the use of this product. The MTA is available at www.atcc.org.
- Disclosures
-
This material is cited in a US and/or international patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Depositor of the party to which the material was furnished.
Frequently Asked Questions
References
Curated Citations
Tom BH, et al. Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro 12: 180-191, 1976. PubMed: 1262041
Tom BH, et al. Process of producing carcinoembryonic antigen. US Patent 4,228,236 dated Oct 14 1980
Chen TR, et al. Intercellular karyotypic similarity in near-diploid cell lines of human tumor origins. Cancer Genet. Cytogenet. 10: 351-362, 1983. PubMed: 6652615
Gastl GA, et al. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55: 96-101, 1993. PubMed: 8344757
Lan MS, et al. Polypeptide core of a human pancreatic tumor mucin antigen. Cancer Res. 50: 2997-3001, 1990. PubMed: 2334903
For product-related inquiries and issues, contact Product Experience:
Hours of Operation
US Eastern Time